Bakuchiol: The Retinol Alternative With One Real Study Behind It

Every retinol alternative claims the results without the irritation, and almost none of them has a trial to show for it. Bakuchiol has one, and it is a good one: a randomized, double-blind, head-to-head trial against retinol, published in the British Journal of Dermatology. The trial is also the whole case, and the marketing has run well past it.

The trial, and what it actually compared

The most frequently cited and most rigorous bakuchiol trial is the 2019 randomized, double-blind, parallel-group study by Dhaliwal and colleagues, published in the British Journal of Dermatology. 44 subjects used either 0.5 percent bakuchiol twice daily or 0.5 percent retinol once daily for 12 weeks. Both groups showed statistically significant and comparable improvements in fine lines, skin firmness, elasticity, and photo-damage. The bakuchiol group experienced significantly less stinging, peeling, and scaling than the retinol group.

The details matter, because the marketing does not mention them. The retinol concentration of 0.5 percent is relatively high for over-the-counter retinol, which may have contributed to the higher irritation in the retinol group. Comparing 0.5 percent bakuchiol to 0.025 percent retinol used conservatively would likely produce a different outcome. The trial ran for 12 weeks, a timeframe at which both ingredients show results, but one that does not capture the longer-term collagen remodeling at which retinoids show their strongest differentiation. And the trial had no placebo arm, which makes it harder to isolate the treatment effect from natural skin variation.

The mechanism is distinct from retinol, and that is the interesting part. Bakuchiol is a meroterpene phenol extracted from the seeds and leaves of Psoralea corylifolia, a plant used in Ayurvedic and traditional Chinese medicine for centuries. It is not a retinoid at all chemically. It does not convert to retinoic acid and does not bind retinoic acid receptors. Research by Chaudhuri and colleagues, published in the International Journal of Cosmetic Science, used gene expression profiling to show that bakuchiol upregulates many of the same genes that retinoic acid does, including several collagen synthesis genes, without binding to retinoid receptors. That is a real mechanism, and it is why the trial result is plausible rather than surprising.

The honest comparison, and where it stops

Bakuchiol produces retinol-like effects through mechanisms that are only partially understood, delivers them more slowly and at lower absolute magnitude than retinol, and genuinely offers a valuable option for specific skin profiles. The honest interpretation is that it performs in a similar ballpark to moderate retinol, with substantially better tolerability. It is a genuine functional alternative for pregnancy, sensitive skin, rosacea, and anyone who cannot tolerate retinoid irritation, with the caveat that the pregnancy claim has no dedicated safety trial behind it.

What the trial does not establish is that bakuchiol is equivalent to 1 percent retinol, or to retinaldehyde, or to prescription tretinoin. The comparison is specifically to 0.5 percent retinol at the frequencies studied. Higher retinol concentrations, 0.3 to 1 percent, have not been directly compared to bakuchiol in published trials. A 2022 systematic review called bakuchiol a promising alternative while noting that a single trial cannot carry the claim that it is retinol's equal. The retinol versus retinal post makes the same point about the retinoid family itself: the conversion steps matter, and the potency ladder is real, and bakuchiol sits beside that ladder rather than on top of it.

The concentration question has a clear answer and an unclear one. The benchmark study used 0.5 percent, and commercial serums range from 0.5 to 2 percent. There is no strong clinical case that higher percentages work better, because the 0.5 percent dose already matched retinol in the only real comparison trial. The 2022 combination study found bakuchiol combined with retinol improved results versus either alone, which suggests the interesting product is not bakuchiol instead of retinol, but bakuchiol alongside a lower retinol dose, for the person who wants the retinoid result with less of the retinoid penalty.

Who it is actually for

The person who cannot tolerate a retinoid, and the person who has tried one twice and quit twice. The trial's tolerability gap is the finding that matters most for them: significantly less stinging, peeling, and scaling, with comparable wrinkle and pigmentation improvement at the studied doses. That is not a consolation prize. For a person with rosacea or reactive skin, tolerability is the outcome, because a product that cannot be used has no efficacy at all.

The person it is not for is the one already tolerating a prescription retinoid and looking for an upgrade. Bakuchiol is not stronger than tretinoin, and no trial says it is. The panthenol post is the same lesson in a quieter register: an ingredient earns its place by doing one thing well for the people it suits, not by replacing the strongest tool in the cabinet. Bakuchiol has one real trial, one real mechanism, and one real population. That is more than almost every retinol alternative can say, and it is enough, as long as nobody claims it is more.

Frequently asked questions

Is bakuchiol as strong as retinol?

In the one well-designed head-to-head trial, 0.5 percent bakuchiol twice daily matched 0.5 percent retinol once nightly for wrinkles and pigmentation over 12 weeks, with less irritation. It has not been compared to 1 percent retinol, retinaldehyde, or prescription tretinoin, so it is not a replacement for those.

What concentration should I look for?

The benchmark study used 0.5 percent bakuchiol, and commercial serums range from 0.5 to 2 percent. There is no strong clinical case that higher percentages work better, because the 0.5 percent dose already matched retinol in the only real comparison trial.

Is bakuchiol safe in pregnancy?

It is marketed that way, but there are no dedicated pregnancy safety trials on topical bakuchiol. The honest position is that the evidence is absent, not that safety is proven, and a clinician is the right person to ask.

Can I use bakuchiol in the morning?

Yes, and that is one of its real advantages. Bakuchiol does not cause the photosensitivity that retinoids do, and it does not require the same sun caution. It still needs sunscreen, because every routine does, but the ingredient itself is not the reason.